Allbirds Inc vs ClearPoint Neuro Inc — how do they compare? Allbirds Inc trades at $2.6 (market cap $30.00M), while ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M). The key difference: ClearPoint Neuro Inc is far larger — about 15.1× Allbirds Inc's market cap, and ClearPoint Neuro Inc is trading nearer its 52-week high, Allbirds Inc nearer its low. Which is the better fit depends on your goals.
| BIRD | CLPT | |
|---|---|---|
Market Cap | $30.00M | $454.21M |
Sector | Consumer Cyclical | Health |
52-Week High | $16.99 | $29.60 |
52-Week Low | $2.21 | $8.66 |
Enterprise Value | $48.86M | $488.79M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ClearPoint Neuro (CLPT) trades at $14.21, up 6.12% today, amid mixed technical signals and challenging fundamentals. The company reported Q2 2026 revenue growth but missed earnings expectations with a loss of $0.38 per share, continuing a trend of negative profitability. Despite 100% analyst buy ratings, financial metrics show significant losses with a net income margin of -81.76% and negative cash flow from operations of $30 million projected for 2026.
The investment case hinges on regulatory progress and partnership developments in neurotechnology, but substantial execution risks and persistent losses present headwinds. While analyst consensus remains bullish on long-term potential, current financial performance suggests cautious optimism is warranted until profitability improves.
Trailing returns across standard periods
Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →